The DEA and HHS announced a third temporary extension of COVID-19 telemedicine flexibilities for prescribing controlled medications, preventing patient medication access issues until December 31, 2025. The agencies are developing final rules for virtual prescribing to ensure public health and safety while addressing concerns over access barriers post-pandemic. They continue to consider feedback from stakeholders.

Healthcare sector braces for rising cybersecurity threats in 2025
A global survey by Health-ISAC shows increasing cybersecurity challenges for healthcare organizations, with ransomware as the prevailing threat. Other concerns include third-party and data breaches,